1.

National Pharmaceutical Pricing Authority (NPPA) has revised the ceiling price of how many scheduled formulations?

Answer» National Pharmaceutical Pricing Authority (NPPA) revised the ceiling price of 883 scheduled formulations on 31 March. It noted the supply disruption of active pharmaceutical ingredients caused by the COVID-19 outbreak is returning to normalcy.


Discussion

No Comment Found